Resultats globals: 25 registres trobats en 0.02 segons.
Articles, 25 registres trobats
Articles 25 registres trobats  1 - 10següentfinal  anar al registre:
1.
10 p, 859.5 KB Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks / Zhang, Y. (University of Oxford) ; Ghose, U. (University of Oxford) ; Buckley, N.J. (University of Oxford) ; Engelborghs, S. (Vrije Universiteit Brussel) ; Sleegers, K. (University of Antwerp) ; Frisoni, G.B. (Department of Psychiatry. University of Geneva) ; Wallin, A. (University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (University of Zürich) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Legido-Quigley, C. (Steno Diabetes Center) ; Barkhof, F. (University College London) ; Zetterberg, H. (Kong Kong Center for Neurodegenerative Diseases) ; Visser, P.J. (VU University Medical Center) ; Bertram, L. (University of Oslo) ; Lovestone, S. (Janssen RD) ; Nevado-Holgado, Alejo (University of Oxford) ; Shi, L. (University of Oxford) ; Universitat Autònoma de Barcelona
Background and objective: Blood-based biomarkers represent a promising approach to help identify early Alzheimer's disease (AD). Previous research has applied traditional machine learning (ML) to analyze plasma omics data and search for potential biomarkers, but the most modern ML methods based on deep learning has however been scarcely explored. [...]
2022 - 10.3389/fnagi.2022.1040001
Frontiers in aging neuroscience, Vol. 14 (29 2022) , p. 1040001  
2.
7 p, 663.7 KB Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort / Verheijen, Jan (University of Antwerp) ; van der Zee, Julie (University of Antwerp) ; Gijselinck, Ilse (University of Antwerp) ; Van den Bossche, Tobi (University Hospital Antwerp (Bèlgica)) ; Dillen, Lubina (University of Antwerp) ; Heeman, Bavo (University of Antwerp) ; Gómez-Tortosa, Estrella (Hospital Universitario Fundación Jiménez Díaz) ; Lladó, Albert (Hospital Clínic i Provincial de Barcelona) ; Sanchez-Valle, Raquel (Hospital Clínic i Provincial de Barcelona) ; Graff, Caroline (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Pastor, Pau (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Pastor, Maria A. (Clínica Universidad de Navarra) ; Benussi, Luisa (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Ghidoni, Roberta (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Binetti, Giuliano (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; de Mendonça, Alexandre (University of Lisbon) ; Gelpi, Ellen (Hospital Clínic i Provincial de Barcelona) ; Tsolaki, Magda (Aristotle University of Thessaloniki) ; Diehl-Schmid, Janine (Technische Universität München) ; Nacmias, Benedetta (University of Florence) ; Almeida, Maria Rosário (University of Coimbra) ; Borroni, Barbara (University of Brescia) ; Matej, Radoslav (Thomayer Hospital in Prague) ; Ruiz, Agustín (Fundació ACE) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; De Deyn, Peter P. (University Hospital Antwerp (Bèlgica)) ; Cruts, Marc (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Sleegers, Kristel (University of Antwerp) ; Goeman, Johan ; Nuytten, Dirk ; Vandenbulcke, Mathieu ; Santens, Patrick 700 1_ ; Sieben, Anne ; Dermaut, Bart ; Versijpt, Jan ; Michotte, Alex ; Deryck, Olivier ; Bergmans, Bruno ; Willems, Christiana ; Ivanoiu, Adrian ; Salmon, Eric ; Alexopoulos, Panagiotis (Technische Universität München) ; Sorbi, Sandro ; Bessi, Valentina ; Bagnoli, Silvia ; Santana, Isabel ; Simões do Couto, Frederico ; Martins, Madalena ; Thonberg, Häkan ; Fratiglioni, Laura ; Padovani, Alessandro ; Rohan, Zdenek ; Razquin, Cristina ; Lorenzo, Elena ; Iglesias, Elena ; Seijo-Martínez, Manuel ; Rene, Ramon ; Gascon, Jordi ; Campdelacreu, Jaume ; Koutroumani, Maria ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
TANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. [...]
2018 - 10.1016/j.neurobiolaging.2017.10.012
Neurobiology of Aging, Vol. 62 (february 2018) , p. 245.e1-245.e7  
3.
9 p, 745.8 KB The EMIF-AD Multimodal Biomarker Discovery study : Design, methods and cohort characteristics / Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (Katholieke Universiteit Leuven) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Engelborghs, Sebastiaan (University of Antwerp) ; Frisoni, Giovanni (IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Fundació Pasqual Maragall) ; Wallin, Anders (Institute of Neuroscience and Physiology) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Martinez-Lage, Pablo (Centro de Investigación y Tecnología Agroalimentaria de Aragón) ; Baird, Alison (University of Oxford) ; Dobson, Richard (NIHR University College London Hospitals) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Bertram, Lars (University of Oslo) ; Ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Barkhof, Frederik (Amsterdam UMC. University Medical Center) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Universitat Autònoma de Barcelona
There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. [...]
2018 - 10.1186/s13195-018-0396-5
Alzheimer's research & therapy, Vol. 10 Núm. 1 (june 2018) , p. 64  
4.
6 p, 731.5 KB A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood : Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort / Stamate, Daniel (University of London) ; Kim, Min (Steno Diabetes Center Copenhagen) ; Proitsi, Petroula (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (King's College London) ; Bos, Isabelle (Amsterdam UMC) ; Vos, Stephanie J.B. (Maastricht University) ; Vandenberghe, Rik (Amsterdam UMC) ; Teunissen, Charlotte E. (Amsterdam UMC. University Medical Center) ; Kate, Mara Ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Bordet, Régis (University of Lille) ; Ramit, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (Fundacion CITA-alzheimer Fundazioa) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at the University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Bertram, Lars (University of Oslo) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, Johannes (University of Antwerp) ; Visser, Pieter J. (Amsterdam UMC) ; Lovestone, Simon (Janssen-Cilag UK Ltd) ; Legido-Quigley, Cristina (King's College London) ; Universitat Autònoma de Barcelona
Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers. [...]
2019 - 10.1016/j.trci.2019.11.001
Alzheimer's & dementia, Vol. 5 (2019) , p. 933-938  
5.
11 p, 783.1 KB Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay / Shi, Liu (University of Oxford) ; Westwood, Sarah (University of Oxford) ; Baird, Alison L. (University of Oxford) ; Winchester, Laura (University of Oxford) ; Dobricic, Valerija (University of Lübeck) ; Kilpert, Fabian (University of Lübeck) ; Hong, Shengjun (University of Lübeck) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J. (South London and Maudsley NHS Foundation) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Amsterdam UMC. University Medical Center) ; Buckley, Noel J (University of Oxford) ; Kate, Mara ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Engelborghs, Sebastiaan (VUB University Hospital Brussels (UZ Brussel)) ; De Roeck, Ellen E. (Institute Born-Bunge. University of Antwerp) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (University of Oxford) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter Copenhagen University Hospital ; Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ; Freund-Levi, Yvonne (King's College London) ; Frölich, Lutz (University of Heidelberg) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Baker, Susan (Janssen R&D) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R&D. LLC) ; Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia)) ; Bertram, Lars (University of Oslo) ; Lovestone, Simon (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Universitat Autònoma de Barcelona
Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. [...]
2019 - 10.1016/j.jalz.2019.06.4951
Alzheimer's & Dementia, Vol. 15 Núm. 11 (november 2019) , p. 1478-1488  
6.
22 p, 986.7 KB Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort / Kim, Min (Steno Diabetes Center Copenhagen) ; Snowden, Stuart (University of Cambridge) ; Suvitaival, Tommi (Steno Diabetes Center Copenhagen) ; Ali, Ashfaq (Steno Diabetes Center Copenhagen) ; Merkler, David J. (University of South Florida) ; Ahmad, Tahmina (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Proitsi, Petroula (King's College London) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (Steno Diabetes Center Copenhagen) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Teunissen, Charlotte (Amsterdam Neuroscience) ; ten Kate, Mara (Amsterdam Neuroscience) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Gabel, Silvy (KU Leuven) ; Meersmans, Karen (KU Leuven) ; Blin, Olivier ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Sleegers, Kristel (VIB) ; Bordet, Régis (University of Lille) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (John Radcliffe Hospital (Oxford, Regne Unit)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Frisoni, Giovanni B. (University of Geneva) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Wallin, Anders (University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (CITA-Alzheimer Foundation) ; Bertram, Lars (University of Lübeck) ; Barkhof, Frederik (Amsterdam Neuroscience) ; Ashton, Nicholas J (University of Gothenburg) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter J. (Amsterdam Neuroscience) ; Lovestone, Simon (University of Oxford) ; Legido-Quigley, Cristina (Steno Diabetes Center Copenhagen) ; Universitat Autònoma de Barcelona
A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers. [...]
2019 - 10.1016/j.jalz.2019.03.004
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 817-827  
7.
13 p, 162.5 KB Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort / Westwood, Sarah (University of Oxford) ; Baird, Alison L (University of Oxford) ; Anand, Sneha N. (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Kormilitzin, Andrey (University of Oxford) ; Shi, Liu (University of Oxford) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J (University of Gothenburg) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Maastricht University) ; Baker, Susan (Janssen R and D) ; Buckley, Noel J (University of Oxford) ; Ten Kate, Mara (Vrije Universiteit University Medical Center) ; Scheltens, Philip (Vrije Universiteit University Medical Center) ; Teunissen, Charlotte E. (Vrije Universiteit University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Ku Leuven) ; Meersmans, Karen (Ku Leuven) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; De Roeck, Ellen E. (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology) ; Frisoni, Giovanni B. (Irccs Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R and D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Geneva University Hospitals) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Bertram, Lars (University of Oslo) ; Barkhof, Frederik (Ucl Institutes of Neurology and Healthcare Engineering) ; Zetterberg, Henrik (Ucl Institute of Neurology) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R and D. Llc) ; Visser, Pieter Jelle (Vu University Medical Center) ; Lovestone, Simon (Janssen R and D) ; Universitat Autònoma de Barcelona
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. [...]
2020 - 10.3233/JAD-190434
Journal of Alzheimer's disease, Vol. 74 Núm. 1 (2020) , p. 213-225  
8.
12 p, 1.3 MB Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset / Hong, S. (University of Lübeck) ; Prokopenko, D. (Massachusetts General Hospital) ; Dobricic, V. (University of Lübeck) ; Kilpert, F. (University of Lübeck) ; Bos, I. (Vrije Universiteit Amsterdam) ; Vos, S.J.B. (Maastricht University) ; Tijms, Betty M (Vrije Universiteit Amsterdam) ; Andreasson, Ulf (Sahlgrenska University Hospital (Suècia)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Cleynen, I. (KU Leuven) ; Gabel, Silvy (KU Leuven) ; Schaeverbeke, J. (KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, C.E. (Vrije Universiteit) ; Niemantsverdriet, E. (University of Antwerp) ; Engelborghs, Sebastiaan (UZ Brussel and Vrije Universiteit Brussel (VUB)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, J.C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, P. (University of Oxford) ; Wallin, Anders (University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (Lausanne University Hospital) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Tainta, M. (CITA-Alzheimer Foundation) ; Dobson, R.J.B. (University College London) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, K. (University of Antwerp) ; Van Broeckhoven, C. (University of Antwerp) ; ten Kate, M. (Amsterdam Neuroscience) ; Barkhof, Frederik (University College London) ; Zetterberg, H. (UK Dementia Research Institute) ; Lovestone, S. (University of Oxford) ; Streffer, J. (UCB Biopharma SPRL) ; Wittig, M. (Christian-Albrechts-University of Kiel) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Tanzi, R.E. (Massachusetts General Hospital) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Bertram, Lars (University of Oslo) ; Universitat Autònoma de Barcelona
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. [...]
2020 - 10.1038/s41398-020-01074-z
Translational psychiatry, Vol. 10 Núm. 1 (december 2020) , p. 403  
9.
22 p, 1.4 MB Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers / Jansen, Iris (Vrije Universiteit Amsterdam) ; van der Lee, Sven J (Vrije Universiteit Amsterdam) ; Gomez-Fonseca, Duber (Washington University School of Medicine) ; De Rojas, Itziar (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Dalmasso, Maria Carolina (Neurosciences and Complex Systems Unit (ENyS). CONICET. Hospital El Cruce. National University A. Jauretche (UNAJ)) ; Grenier-Boley, Benjamin (Université de Lille) ; Zettergren, Anna (University of Gothenburg) ; Mishra, Aniket (Université de Bordeaux) ; Ali, Muhammad (Washington University School of Medicine) ; Andrade, Victor (University Hospital Bonn. Medical Faculty) ; Bellenguez, Céline (Université de Lille) ; Kleineidam, Luca (German Center for Neurodegenerative Diseases (DZNE)) ; Küçükali, Fahri (University of Antwerp. Department of Biomedical Sciences) ; Sung, Ju Sung (Washington University School of Medicine) ; Tesí, Niccolo (Vrije Universiteit Amsterdam) ; Vromen, Ellen (Amsterdam Neuroscience. Neurodegeneration) ; Wightman, Douglas P (Vrije Universiteit Amsterdam) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Alegret, Montserrat (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Alvarez, Ignacio (Fundació per a la Recerca Biomèdica i Social Mútua de Terrassa) ; Amouyel, Philippe (Université de Lille) ; Athanasiu, Lavinia (NORMENT Centre. Institute of Clinical Medicine. University of Oslo and Division of Mental Health) ; Bahrami, Shahram (NORMENT Centre. Institute of Clinical Medicine. University of Oslo and Division of Mental Health) ; Bailly, Henri (Université Paris Cité) ; Belbin, Olivia (Institut d'Investigació Biomèdica Sant Pau) ; Bergh, Sverre (Vestfold Hospital Trust) ; Bertram, Lars (University of Lübeck) ; Biessels, Geert Jan (UMC Utrecht Brain Center) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Blesa, Rafael (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Boada, Mercè (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Boland, Anne (Université Paris-Saclay. Centre National de Recherche en Génomique Humaine) ; Buerger, K. (Institute for Stroke and Dementia Research (ISD). University Hospital. LMU Munich) ; Carracedo, Ángel (Fundación Pública Galega de Medicina Xenómica-CIBERER-IDIS) ; Cervera Carles, Laura (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Chene, Geneviève (Department of Neurology. CHU de Bordeaux) ; Claassen, Jurgen (Donders Center for Medical Neuroscience) ; Debette, Stephanie (University School of Medicine) ; Deleuze, Jean‑Francois (Université Paris-Saclay. Centre National de Recherche en Génomique Humaine) ; De Deyn, Peter Paul (University Medical Center Groningen. Department of Neurology and Alzheimer Center Groningen.) ; Diehl-Schmid, Janine (kbo-Inn-Salzach-Hospital) ; Djurovic, Srdjan (University of Bergen. Department of Clinical Science. NORMENT Centre.) ; Dols Icardo, Oriol (Institut d'Investigació Biomèdica Sant Pau) ; Dufouil, Carole (Pôle de Santé Publique) ; Duron, Emmanuelle (Univerisité Paris-Saclay) ; Düzel, Emrah (Otto-von-Guericke University Magdeburg. Institute of Cognitive Neurology and Dementia Research) ; Fladby, Tormod (Akershus University Hospital. Department of Neurology.) ; Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Frölich, Lutz (Medical Faculty Mannheim. Department of Geriatric Psychiatry. Central Institute of Mental Health.) ; García-González, Pablo (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Garcia-Martinez, María (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Giegling, Ina (Medical University of Vienna) ; Goldhardt, Oliver (Technical University of Munich) ; Gobom, Johan (Sahlgrenska University Hospital (Suècia)) ; Grimmer, Timo (Technical University of Munich) ; Haapasalo, Annakaisa (University of Eastern Finland A.I. Virtanen Institute for Molecular Sciences) ; Hampel, Harald (Neurology Business Group. Eisai Inc) ; Hanon, Olivier (Service gériatrie. Centre Mémoire de Ressources et Recherches Ile de France-Broca. AP-HP. Hôpital Broca) ; Hausner, Lucrezia (Central Institute of Mental Health. Department of Geriatric Psychiatry) ; Heilmann-Heimbach, Stefanie (Institute of Human Genetics. University of Bonn. School of Medicine and University Hospital Bonn) ; Helisalmi, Seppo (University of Eastern Finland. Institute of Clinical Medicine) ; Heneka, Michael (German Center for Neurodegenerative Diseases (DZNE)) ; Hernández, Isabel (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Herukka, Sanna‑Kaisa (University of Eastern Finland. Department of Neurology. Institute of Clinical Medicine) ; Holstege, Henne (Vrije Universiteit Amsterdam. Section Genomics of Neurodegenerative Diseases and Aging) ; Jarholm, Jonas (Akershus University Hospital. Department of Neurology.) ; Kern, Silke (Sahlgrenska University Hospital. Psychiatry. Cognition and Old Age Psychiatry Clinic) ; Knapskog, Anne‑Brita (Oslo University Hospital. Department of Geriatric Medicine) ; Koivisto, A.M. (Department of Neurology. Helsinki University Hospital) ; Kornhuber, Johannes (Friedrich-Alexander Universität Erlangen-Nürnberg) ; Kuulasmaa, Teemu (University of Eastern Finland) ; Lage, Carmen (University of California) ; Laske, Christoph (University of Tübingen. Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy.) ; Leinonen, Ville (Kuopio University Hospita. Department of Neurosurgery.) ; Lewczuk, Piotr (Medical University of Białystok. Department of Neurodegeneration Diagnostics.) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; López de Munain, Adolfo (University of The Basque Country) ; López-Garcia, Sara (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Maier, Wolfgang (University Hospital Bonn. Department of Neurodegenerative Diseases and Geriatric Psychiatry) ; Marquié, Marta (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Mol, Merel O. (Erasmus Medical Centre. Department of Neurology) ; Montrreal, Laura (Universitat Internacional de Catalunya. Ace Alzheimer Center Barcelona) ; Moreno, Fermin (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Moreno-Grau, Sonia (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Nicolas, Gael (Normandie Univ. UNIROUEN. Department of Genetics and CNR-MAJ) ; Nöthen, Markus M. (Institute of Human Genetics. University of Bonn. School of Medicine and University Hospital Bonn) ; Orellana, Adelina (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Pålhaugen, Lene (Akershus University Hospital. Department of Neurology) ; Papma, Janne M. (Erasmus MC University Medical Center. Department of Neurology and Alzheimer Center Erasmus MC) ; Pasquier, Florence (Université Lille) ; Perneczky, Robert (Imperial College London. Ageing Epidemiology Research Unit) ; Peters, Oliver (German Center for Neurodegenerative Diseases (DZNE)) ; Pijnenburg, Yolande A.L. (Amsterdam Neuroscience. Neurodegeneration) ; Popp, Julius (University Hospital of Lausanne. Department of Psychiatry) ; Posthuma, Danielle (Vrije Universiteit Amsterdam) ; Pozueta, Ana (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Priller, Josef (Technical University Munich. Department of Psychiatry and Psychotherapy) ; Puerta, Raquel (Universitat Internacional de Catalunya. Ace Alzheimer Center Barcelona) ; Quintela, Inés (Grupo de Medicina Xenómica. Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII). Universidade de Santiago de Compostela) ; Ramakers, Inez (Maastricht University. Department of Psychiatry and Neuropsychologie) ; Rodríguez-Rodríguez, Eloy (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Rujescu, Dan (Medical University of Vienna. Department of Psychiatry and Psychotherapy) ; Saltvedt, Ingvild (University Hospital of Trondheim. Department of Geriatrics) ; Sánchez-Juan, Pascual (Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII) ; Scheltens, Philip (Amsterdam Neuroscience. Neurodegeneration) ; Scherbaum, Norbert (University of Duisburg-Essen) ; Schmid, Matthias (University Hospital of Bonn. Institute of Medical Biometry) ; Schneider, Anja (German Center for Neurodegenerative Diseases (DZNE)) ; Selbæk, Geir (Oslo University Hospital.Department of Geriatric Medicine) ; Selnes, Per (Akershus University Hospital. Department of Neurology) ; Shadrin, Alexey (University of Oslo and Division of Mental Health. Institute of Clinical Medicine) ; Skoog, Ingmar (Sahlgrenska University Hospital (Suècia)) ; Soininen, Hilkka (University of Eastern Finland. Institute of Clinical Medicine.) ; Tárraga, Lluís (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Teipel, Stefan (Rostock University Medical Center. Department of Psychosomatic Medicine) ; Tijms, Betty M (Amsterdam Neuroscience. Neurodegeneration) ; Tsolaki, Magda (Aristotle University of Thessaloniki) ; Van Broeckhoven, Christine (Neurodegenerative Brain Diseases Group. VIB Center for Molecular Neurology. VIB) ; Van Dongen, Jasper (University of Antwerp. Department of Biomedical Sciences) ; van Swieten, John C. (Erasmus MC University Medical Center) ; Vandenberghe, Rik (Leuven Brain Institute. Department of Neurosciences.) ; Vidal, Jean‑Sébastien (Université Paris Cité) ; Visser, Pieter J. (Division of Neurogeriatrics Karolinska Institutet. Department of Neurobiology) ; Vogelgsang, Jonathan (Harvard Medical School. Department of Psychiatry) ; Waern, Margda (Sahlgrenska University Hospital (Suècia)) ; Wagner, Michael (German Center for Neurodegenerative Diseases (DZNE)) ; Wiltfang, Jens W (Medical Science Department. iBiMED) ; Wittens, Mandy M.J. (Vrije Universiteit Brussel) ; Zetterberg, Henrik (Hong Kong Center for Neurodegenerative Diseases) ; Zulaica, Miren (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; van Duijn, Cornelia M. (Nuffield Department of Population Health. Oxford University) ; Bjerke, Maria (Universitair Ziekenhuis Brussel) ; Engelborghs, Sebastiaan (Universitair Ziekenhuis Brussel. Department of Neurology) ; Jessen, Frank (University of Cologne) ; Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ; Pastor, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hiltunen, Mikko (University of Eastern Finland. Institute of Biomedicine) ; Ingelsson, Martin (University of Toronto. Department of Medicine) ; Andreassen, Ole A (Oslo University Hospital (Oslo, Noruega)) ; Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sleegers, Kristel (University of Antwerp. Department of Biomedical Sciences) ; Ruiz, Agustín (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Ramirez, Alfredo (Department of Psychiatry. Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases) ; Cruchaga, Carlos (Washington University School of Medicine. Hope Center for Neurological Disorders) ; Lambert, Jean-Charles (Institut Pasteur de Lille) ; van der Flier, Wiesje M (Amsterdam Neuroscience. Neurodegeneration) ; Universitat Autònoma de Barcelona
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). [...]
2022 - 10.1007/s00401-022-02454-z
Acta Neuropathologica, Vol. 144 Núm. 5 (november 2022) , p. 821-842  
10.
14 p, 3.0 MB Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset / Homann, Jan (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Osburg, Tim (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Ohlei, Olena (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Dobricic, Valerija (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Deecke, Laura (Lübeck Interdisciplinary Platform for Genome Analytics. University of Lübeck) ; Bos, Isabelle (Vrije Universiteit Amsterdam) ; Vandenberghe, Rik (Neurology Service. University Hospital Leuven) ; Gabel, Silvy (Laboratory for Cognitive Neurology. Department of Neurosciences. KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ; Engelborghs, Sebastiaan (Vrije Universiteit Amsterdam) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Institut Neurosciences Timone. AIX Marseille University) ; Richardson, Jill C. (Neurosciences Therapeutic Area. GlaxoSmithKline RD) ; Bordet, Régis (Lille Neuroscience and Cognition. University of Lille. Inserm. CHU Lille) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Old Age Psychiatry. Department of Psychiatry. University Hospital of Lausanne) ; Clark, Christopher (Department of Geriatric Psychiatry. University Hospital of Psychiatry Zurich) ; Peyratout, Gwendoline (Old Age Psychiatry. Department of Psychiatry. University Hospital of Lausanne) ; Martinez-Lage, Pablo (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Tainta, Mikel (Department of Neurology. Center for Research and Advanced Therapies. CITA-Alzheimer Foundation) ; Dobson, Richard J.B. (NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust) ; Legido-Quigley, Cristina (King's College London. Institute of Pharmaceutical Sciences) ; Sleegers, Kristel (Center for Molecular Neurology) ; Van Broeckhoven, Christine (University of Antwerp) ; Wittig, Michael (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Franke, Andre (Christian-Albrechts-University of Kiel. Institute of Clinical Molecular Biology) ; Lill, Christina M. (Ageing Epidemiology Research Unit. School of Public Health. Imperial College London) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (University College London. UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford. Department of Psychiatry) ; Streffer, Johannes ; ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Vos, Stephanie J.B. (Maastricht University) ; Barkhof, Frederik (University College London) ; Visser, Pieter Jeller (Karolinska Institutet. Department of Neurobiology) ; Bertram, Lars (University of Oslo)
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with an increasing prevalence in industrialized, aging populations. AD susceptibility has an established genetic basis which has been the focus of a large number of genome-wide association studies (GWAS) published over the last decade. [...]
2022 - 10.3389/fnagi.2022.840651
Frontiers in aging neuroscience, Vol. 14 (March 2022) , p. 840651  

Articles : 25 registres trobats   1 - 10següentfinal  anar al registre:
Vegeu també: autors amb noms similars
24 Sleegers, Kristel
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.